1. 1) WHO. “Substandard and falsified medical products, Fact sheet, 2018.”: ‹https://www.who.int/news-room/fact-sheets/detail/substandard-and-falsified-medical-products›, accessed 9 April, 2020.
2. 2) WHO. “Assembly document A70/23, Appendix 3 to Annex, 2017.”: ‹http://apps.who.int/gb/ebwha/pdf_files/WHA70/A70_23-en.pdf›, accessed 20 January, 2020.
3. 3) WHO. “Counterfeit medicines, Fact sheet, Revised November 2006.”: ‹https://www.wipo.int/edocs/mdocs/enforcement/en/third_global_congress/third_global_congress_ref_z3.pdf›, accessed 6 December, 2020.
4. 4) WHO. “WHO global surveillance and monitoring system for substandard and falsified medical products, reports and executive summary, November 2017.”: ‹https://www.who.int/medicines/regulation/ssffc/publications/GSMSreport_EN.pdf?ua=›, accessed 10 August, 2020.
5. 5) Sato D. Counterfeit medicines—Japan and the world. Yakugaku Zasshi, 134, 213–222 (2014).